Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 110,993 | 57,284 | 91,221 | 13,944 | -10,925 |
| Depreciation Amortization | 17,246 | 7,619 | 2,919 | 1,669 | 3,018 |
| Income taxes - deferred | -4,167 | 21,224 | -41,787 | 0 | 0 |
| Accounts receivable | -35,856 | -24,059 | -15,619 | -8,638 | -12,216 |
| Other Working Capital | -4,734 | 23,710 | 8,448 | 12,173 | -19,099 |
| Other Operating Activity | 45,504 | 28,862 | 21,630 | 15,376 | 14,727 |
| Operating Cash Flow | $128,986 | $114,640 | $66,812 | $34,524 | $-24,495 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -411,827 | -73,232 | -15,540 | -26,278 | 211 |
| PPE Investments | -844 | -2,029 | -1,603 | -2,104 | -593 |
| Purchase Sale Intangibles | N/A | N/A | -18,821 | -10,907 | -2,277 |
| Other Investing Activity | -809 | -11,154 | -18,821 | -10,907 | -2,277 |
| Investing Cash Flow | $-413,480 | $-86,415 | $-35,964 | $-39,289 | $-2,659 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 402,500 | 0 | N/A | N/A | N/A |
| Common Stock Issued | 11,582 | 5,681 | 2,052 | 1,867 | 571 |
| Other Financing Activity | -37,644 | 0 | 0 | 0 | 29,999 |
| Financing Cash Flow | $376,438 | $5,681 | $2,052 | $1,867 | $30,570 |
| Beginning Cash Position | 100,304 | 66,398 | 33,498 | 36,396 | 32,980 |
| End Cash Position | 192,248 | 100,304 | 66,398 | 33,498 | 36,396 |
| Net Cash Flow | $91,944 | $33,906 | $32,900 | $-2,898 | $3,416 |
| Free Cash Flow | |||||
| Operating Cash Flow | 128,986 | 114,640 | 66,812 | 34,524 | -24,495 |
| Capital Expenditure | -844 | -2,029 | -1,603 | -2,104 | -593 |
| Free Cash Flow | 128,142 | 112,611 | 65,209 | 32,420 | -25,088 |